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In vitro cell cytotoxicity profile and morphological
response to polyoxometalate-stabilised gold
nanoparticles†
Isabel Maicas Gabas,‡a Grazyna Stepien,‡a Marı´a Moros,*c Scott G. Mitchell*b and
Jesu´s M. de la Fuenteb
The size and redox properties of molecular polyoxometalates (POMs) make them extremely relevant for
bioapplications: from disrupting tumour growth and enzyme inhibition, to DNA-intercalating agents and
antimicrobial applications. Their unique ability to reversibly dominate and receive electrons, coupled with
their high anionic charge, also makes them suitable for the preparation of zero-valent state metal
nanoparticles (NPs) from molecular precursors. Polyoxometalate-stabilised nanoparticles (NPs@POM) are
therefore an ideal delivery vehicle for bioactive POMs. Here we show how POM-stabilised gold NPs
(AuNPs@POM) are massively internalised into Vero (kidney epithelial) and B16 (skin melanoma) cell lines with
variable cytotoxic effects. Cell viability assays and quantification of cytoplasmic membrane composition
revealed that the Vero cell line was unaltered by the internalisation of these hybrid particles; while their
internalisation in B16 tumour cells produced mild cytotoxic effects and an antiproliferative cell cycle arrest in
the G0/G1 and G2/M phases. The observed perturbation of the tumour cell line combined with the high
degree of internalisation means that these (or similar) NPs@POM could serve as candidates for a range of
bioapplications in diagnostics or therapy.
Introduction
The size-dependent physicochemical properties of colloidal
nanomaterials can be tuned to achieve enhanced or specific
magnetic, optical and electronic properties when compared to
their constituent parts.1 The combination of their nanometre
size and their unique physiochemical features enable nanomaterials
to operate at the biomolecular level, lending them to a wide
variety of applications for biomedical and biotechnological
applications such as photothermal therapy,2 optoacoustic imaging3
as well as colorimetric and thermal biosensors.4 The properties of
gold andmagnetic nanoparticles (NPs) lend themselves particularly
well to applications relating to diagnosis, drug delivery, imaging,
treatment and theranostics.5 The combination of nanoparticle size,
shape and surface chemistry exerts significant influence on their
desired function.6 The overwhelming diversity of NP size and
shape is determined by a combination of thermodynamic (i.e.
temperature, reduction potential) and kinetic factors (i.e. reactant
concentration, diffusion, solubility concentration rate) during
synthesis,7 while the type of capping/stabilising agent can be
modified either during or post-synthesis of the particles.8 Stabilising
agents act to prevent NPs from agglomerating and most commonly
are small organic molecules or polymeric materials.
Polyoxometalates (herein POMs) are oligomeric aggregates
of metal cations (usually the d0 species V(V), Nb(V), Ta(V), Mo(VI),
and W(VI)) bridged by oxide anions that form by self-assembly
processes.9 Due to their unique ability to reversibly accept and
release electrons without change in their structural conformation,10
POMs are model electron-transfer catalysts and can act as reducing
agents for preparation of a wide variety of metallic NPs such as Pt,
Pd, Ru, Au and Ag.11 Importantly, the high negative charge of
POMs also makes them ideal electrostatic stabilising agents to
the forming NPs.12 Although POMs are traditionally employed in
catalysis,13 they have also been shown to be extremely efficient
inorganic antiviral, antitumoural and antimicrobial agents.14
Hill and co-workers, who have contributed a great deal to POM
antiviral research, reviewed the use of POMs in medicine almost
20 years ago.15 A decade ago Yamase reviewed the most recent
advances in antimicrobial and antitumoural applications of POMs.14
Although several stimulating and insightful reports have been
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published recently, the use of POMs in medicine has largely
fallen by the wayside. One reason for this may be because, at
least in practical terms, if POMs are to be used as novel drugs,
drug-delivery agents, sensors, antimicrobial agents and so
forth, an understanding of the cellular behaviour and location
of POMs (or POM conjugates) is critical, and unfortunately
these remain poorly studied and little understood. It is generally
acknowledged that non-covalent binding influenced by the size,
shape, and charge density of POMs is the key to their biological
activity, yet very little is known about the reactivity of POMs
towards biological molecules. For example, although the cellular
cytotoxicity and internalisation of POM-based nanomaterials has
been profiled16 a recent review has discussed how extracellular
target proteins as well as proteins integrated into the cell
membrane with binding sites accessible from the extracellular
space are the most likely sites of interaction with POMs and are
the most likely factors affecting their pharmacological activity.17
Recent work on POMs as artificial proteases18 and non-enzymatic
peptidases19 is contributing substantially to this area.
Yet for POMs to be used more abundantly in diagnostics or
therapy they clearly benefit from being supported in order to
increase dispersion of the ‘active’ POM. Furthermore, site-specific
delivery could also be addressed, for example by using POM-coated
magnetic NPs, or NPs covered with peptide-conjugated POMs. NPs
undoubtedly provide useful and convenient supports for POMs
with respect to bioapplications and gold nanoparticles (AuNPs)20
offer a convenient starting point for in vitro studies on NP@POM
hybrid materials for several reasons. POM-stabilised AuNPs
(AuNPs@POM) are now well-known and their nanometre size
(typically 10–50 nm), optical properties and high electron density
means that their cellular uptake and intracellular location can be
studied using dark field and electron microscopies.
We have recently reported a combined theoretical/experimental
approach to the synthesis of pseudo-spherical AuNPs@POMs
where AuNPs of diameter ca. 29 nm were synthesised and
stabilised with the Kabanos-type POM [Na{(MoV2O4)3(m2-O)3-
(m2-SO3)3(m6-SO3)}2]
15–21 We wanted to investigate the behaviour
of these same all-inorganic AuNPs@POM in vitro. By doing so we
aimed to study their cell-internalisation capacity and investigate
whether their internalisation triggered any cytotoxic effects.
Herein we report in vitro studies on AuNPs@POM detailing their
cellular uptake and cytotoxicity at different levels in Vero (kidney
epithelial) and B16 (mouse melanoma) cell lines.
Results and discussion
Synthesis of polyoxometalate-stabilised gold nanoparticles
(AuNPs@POM)
Both the Kabanos-type POM22 [Na{(MoV2O4)3(m2-O)3(m2-SO3)3-
(m6-SO3)}2]
15 and the AuNPs@POM21 were synthesised according
to reported experimental procedures. The non-classical Kabanos
POM was chosen for this work because it contains two layers of
hexanuclear polyoxomolybdenum(V) sulfite anions with all Mo
atoms in a one-electron reduced oxidation state,Mo(V), meaning that
it has ‘in-built’ reduction capabilities, i.e. no need for electro- or
photo-reduction of the POM prior to their use in the synthesis of
AuNPs.23 Briefly, AuNPs@POM were formed by adding 50 mg
(0.019 mmol) of [Na{(MoV2O4)3(m2-O)3(m2-SO3)3(m6-SO3)}2]
15 single
crystals to 100 mL 0.667 mM HAuCl4(aq) at pH 5 under magnetic
stirring. The pale yellow colour of the AuIII chloroauric acid solution
quickly turned transparent upon addition of the POM, turning dark
red after several minutes. After 30min, UV-vis spectroscopy analysis
of the colloidal material showed one dominant localised surface
plasmon resonance (LSPR) band at 535 nm corresponding to
polyhedral gold nanoparticles. The colloidal material was washed
with Milli-Q water to remove unwanted by-products (including a
minor amount of triangular gold nanoprisms) and reagents via
multiple centrifugation/resuspension steps. Transmission Electron
Microscopy (TEM) characterisation of the AuNPs@POM was used
to obtain additional information on the size and shape of the
nanoparticles which possessed a mean diameter of 29 nm. FTIR,
XPS and EDX analysis of dried AuNPs and ICP analysis of a digested
sample comprehensively confirm the presence of an oxomolybdate
species stabilising the surface of the AuNPs (Fig. 1).§21
Suitability of AuNPs@POM for cell studies
In the first instance, before any cell studies were performed the
sterilisation of these particular hybrid NPs had to be evaluated,
along with their potential to aggregate and precipitate in cell
culture media. Monodisperse AuNPs@POM were sterilised by
passing them through a 0.2 mm PVDF membrane filter, because
other sterilisation techniques can severely affect the integrity of
the physicochemical properties of AuNPs.24
Once the AuNPs@POM had been successfully filtered and
showed no signs of aggregation, they were incubated in DMEM
(Dulbecco’sModified EagleMedium) containing 10% of inactivated
foetal bovine serum (FBS) for 24 h at 37 1C. Unspecific adsorption
of proteins from the culture media onto the surface of the NPs
(protein corona) can lead to the NP aggregation. This aggregation
can influence the interaction of the NPs with the cells, since cellular
uptake depends heavily on both their size and morphology.25
The absence of any signs of aggregation by optical microscopy
e.g. Au0 deposits on the bottom of well-plates, cloudy precipitate
in the cell medium, meant that the cell studies could proceed as
planned. Prior to assessing the in vitro toxicity profile of the NPs,
we aimed to expose the precise location of the AuNPs@POM
Fig. 1 (a) HAADF-STEM and (b) HR-TEM images of AuNPs@POM.
§ Please refer to ref. 21 for full experimental and characterisation details for the
AuNPs@POM.
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accumulated within cells, so their cell-internalisation was assessed
using Transmission Electron Microscopy (TEM).
Morphological analysis of cells using transmission electron
microscopy
The precise location of nanoparticles within the cells was
obtained using resin-bound cells that were cut with a microtome
into ultra-thin slices and stained for electron microscopy investiga-
tions. The representative B16 cell sample was incubated with
0.1 mg mL1 AuNPs@POM for 24 h prior being fixed with
glutaraldehyde, post-fixed with osmium tetroxide and embedded
in Durcupan resin. Semi-thin 1.5 mm sections were cut several
times until ultra-thin sections of o0.08 mm were obtained.
Samples were stained lightly with toluidine blue for TEM imaging.
A reference B16 cell sample was left untreated as a control.
TEM analysis of the treated cells shows that no significant
morphological differences were observed after treatment when
compared with the control cells, specifically, no autophagic
features, e.g. vesicles were observed. Importantly, for the B16
cells treated with AuNPs@POM several high contrast regions
corresponding to considerable amounts of NPs were observed
(Fig. 2). Selected areas were investigated at highermagnifications as
shown in Fig. 2e and f. The dark contrast is due to the high electron
density of the AuNPs and it is clear that the majority of these
particles are located in the cytoplasm, contained entirely within the
endosomes. While each endosome was filled with several hundred
AuNPs@POM, none were observed close to (or associated with) the
cell membrane.
The electron microscopy studies of the resin-bound B16 cells
pinpointed the precise location of the AuNPs@POM within the
cells and showed an apparent absence of morphological
changes, commensurate with a relative lack of cytotoxicity.
ln vitro cell toxicity assays
To date, there are no standardised protocols for assessing the
toxicity of the NPs. It has been widely reported that the
cytotoxicity depends on many factors, such as the size, shape,
composition of the NP, cellular line, incubation time or even the
selected assay.26 It is therefore clear that to test the cytotoxicity
different cell lines must be used due to possible differences in
their origin and proliferative capacity.24 Furthermore, the use of
different cell viability assays will led to a deeper understanding
of any observed cytotoxic effects.
Cell viability assays. In the first instance, the viability of cells
treated with AuNPs@POMwas investigated using MTT assays, a
colorimetric assay for assessing cell viability. MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is a yellow
tetrazole dye that is reduced to its insoluble form, purple formazan
crystals, by the NAD(P)H-dependent succinate dehydrogenase,
a mitochondrial enzyme in living cells. Thus reflecting, under
defined conditions, the number of viable living cells present in
the sample. For that purpose B16 and Vero cells were incubated
with various concentrations of AuNPs@POM for 24 h. Afterwards
the cells were thoroughly washed with PBS and incubated with
MTT as described in experimental section. Results for different
concentrations are shown in Chart 1. Sextets were performed (twice)
for the control experiments and for each concentration of AuNPs@
POM to determine the standard deviation and reproducibility of the
results.
The MTT analysis revealed that the AuNPs@POM do not
cause excessive cell death after 24 h incubation at the tested
concentrations, especially in the case of Vero cells (Chart 1). In
Vero cells (Chart 1a), the percentage of living cells was ca. 90–93%
in all tested concentrations. However, in B16 cells (Chart 1b), the
effect wasmore pronounced, and cell viability was already impaired
at the lowest tested concentration in comparison with the control
sample. At higher AuNPs@POM concentrations, a more significant
decrease of the B16 viability was observed and at 0.1 mg mL1
viability was 72%. These findings demonstrate that AuNPs@POM
do exert cytotoxic action and affect the normal proliferation in B16
cells, contributing to their deleterious effect on this particular
tumour cell line. It is noteworthy that control MTT cell viability
assays of the molecular POM at the same concentrations found on
the AuNP surface, show that the POM alone has less cytotoxic effect
and only exerts minor antiproliferative action in B16 cells at
significantly elevated concentrations (Graph S1, ESI†). As a result
Fig. 2 (a and b) Representative survey image of untreated B16 cells
(control: no AuNPs@POM); (c–f) B16 cells treated with 0.1 mg mL1
AuNPs@POM clearly exhibiting the internalisation of the hybrid particles.
Higher magnifications (e and f) pinpoint their location within endosomes.
AuNPs@POM were not found associated to the cell membrane, nor were
they observed within the nucleus.
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we postulate that it is the synergic combination of POM with
AuNP in the AuNPs@POM hybrids that induces observed cellular
toxicity in B16 cells, possibly affecting the transmembrane
receptor(s) (Chart 1b).
Although MTT assays have routinely been performed on
molecular POMs27 currently there are very little available data
concerning MTT assays on POM-stabilised NPs. However, a recent
report discussing tyrosine-reduced AgNPs with phosphotungstic
acid or phosphomolybdic acid surface coronas as antimicrobial
agents also detailed concentration dependent MTT assays against
human PC3 epithelial cells.28 Although these particular AgNPs
demonstrated significant antibacterial activity against Escherichia
coli and Staphylococcus albus, none of the particles showed any
significant toxicity, morphology or cell density changes to the
PC3 cells up to the highest concentrations. In 2011, Patzke and
co-workers reported MTT assays for supramolecular {EuSiW11O19}/
carboxymethyl chitosan nanocomposites.16 They reported that the
viability of HeLa cells decreased to 80% upon extended incubation
times (24 and 48 h) at the maximum tested POM concentration
(2 mg mL1), whereas POMs encapsulated in the chitosan
nanocomposite produced no cytotoxic effects at the same
concentrations. Another recent study used MTT to evaluate
the use of ‘Mo POM NPs’ to inhibit tumour growth and vascular
endothelial growth factor induced angiogenesis; however, the
tested compounds were not colloidal nanocrystals coated with
POMs, but rather archetypal nanoscale POM clusters.29 Neverthe-
less, it is worth mentioning that the authors reported MTT assays
on Human Umbilical Vein Endothelial Cells (HUVECs), human
hepatocellular liver carcinoma cells (HepG2), human melanoma
cells (A375), breast cancer cells (MCF-7), and human low differ-
entiation nasopharyngeal carcinoma cells (CNE-2). High cytotoxic
effects of ‘Mo POMNPs’ against HepG2 tumoural cells and HUVEC
cells indicated that these ‘Mo POM NPs’ showed higher preference
in the HUVEC and HepG2 cells on cell proliferation.
Consequently, in order to more precisely quantify the cyto-
toxicity profile of the AuNPs@POM in Vero and B16 cells and to
investigate the apparent difference in response to internalised
particles, flow cytometry analysis was performed to quantify the
apoptosis/necrosis in each cell line.
Quantification of apoptosis/necrosis. Cell analysis by flow
cytometry allows a more accurate quantification of cell viability
by obtaining representative populations of viable (living), apoptotic
(dying) and necrotic (dead) cells following incubation with various
concentrations of AuNPs@POM. Apoptosis is a form of genetically
encoded (programmed) cell death – a capability possessed by all
cells. Apoptotic cells are inactivated, disassembled and prepared to
degrade their own structure and components in a characteristic
and coordinated way. One of the early events in apoptosis is the
expression of cell surface markers. During apoptotic cell death,
phosphatidylserine translocates from the internal to the external
face of the plasma membrane, exposing it to the extracellular side.
Annexin V (AnnV) has a specific affinity for the phosphatidylserine,
therefore attached to a fluorochrome such as FITC, is widely used
to detect cells undergoing apoptosis. On the other hand, propidium
iodide (PI) is a DNA-intercalating agent that commonly used to
evaluate membrane integrity due to the fact that this molecule is
only able penetrate the plasma membrane of a cell when the
membrane is disrupted. A disrupted plasma membrane is typical
of necrosis and late apoptosis. Flow cytometry can thus easily
distinguish between living (AnnV PI), apoptotic (AnnV+ PI),
necrotic (AnnV PI+) and late apoptotic/secondary necrotic
(AnnV+ PI+) cells.
For Vero cells incubated with AuNPs@POM at all of the
aforementioned concentrations (from 0.02–0.1 mg mL1) for
24 h, approximately 93–95% were shown to be alive, 5–6%
necrotic and 0.1–0.3% apoptotic, with very little variation
amongst each of the tested concentrations (Fig. 3a). This data
is commensurate with little or no toxicity when compared to the
control sample. The same experiments in the B16 cell line
showed little variation on this theme until the highest tested
concentration (Fig. 3b). Upon incubation with 0.1 mg mL1
particles where the number of living cells dropped to 90% and
necrotic cells increased to almost 10%, illustrating a general
cytotoxicity trend.
From this analysis of cytoplasmic membrane integrity it is
evident that, compared to control experiments, there is no
significant cytotoxicity to the Vero cell population at the tested
concentrations of AuNPs@POM; while a cytotoxicity trend is
Chart 1 (a and b) Concentration-dependent MTT assay cell viability results
of AuNPs@POM incubated for 24 h at 37 1C with Vero and B16 cells,
respectively. The measured absorbance from control (blank cells without
AuNPs@POM) was treated as 100% of viable cells. Black asterisks show
AuNPs@POM concentrations at which the viability was found to be statistically
significant in comparison with control cells (*po 0.05, **po 0.01).
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evident in the B16 tumour cell line (Fig. 3). The general trend is
that the particles are non-toxic at lower concentrations, but that
the B16 cell line is more susceptible to the internalisation of the
particles. It is also important to note that the differences
between the MTT assays and flow cytometry data are much
more pronounced in B16 than for Vero cells. It must be pointed
out that MTT assays are suitable for the determination of viable
cells, but cannot distinguish between quiescent or actively
dividing cells. Therefore to gain more insight into the possible
toxicity at the cellular level, we studied cell cycle analysis to
determine the influence of the AuNPs@POM on cell division
and proliferation.
Cell cycle analysis. The cell cycle is the process by which
eukaryotic cells duplicate and divide. The cell cycle consists of
different phases, tightly regulated: interphase where a cell grows,
replicates DNA and prepares to divide, and a mitotic phase (M),
were the cell divides into two daughter cells. Interphase consist
in different steps: G1 (grow), S (synthesis), and G2 (prepare to
divide). To detect potential DNA damage checkpoints exist, and
each of the phases of the cell cycle are strictly regulated. Apoptotic
cells can be identified in subG1 phase. To assess the cell cycle by
DNA content, cells were stained with propidium iodide (PI) and
analysed using flow cytometry. The stoichiometric binding of PI to
DNA means that the amount of cellular DNA can be quantified via
the amount of fluorescent signal recorded.
The presence of the AuNPs@POM in treated cells in each
phase of the cell cycle was compared to the control cells (no
particles). In Vero cells, none of the tested concentrations
evoked significant changes in the cell cycle phases (Fig. 4a).
However, the AuNPs@POM led to a significant perturbation in
the B16 cell cycle (Fig. 4b). Indeed, for the B16 cell line an
accumulation of cells (cell cycle arrest) in G0/G1 and G2/M
phases occurred, with a concurrent reduction of the cell population
in S phase. As expected, and in line with the previous apoptosis/
necrosis studies (Fig. 3b), no increment in the apoptotic fraction
was found (Sub G1). These results suggest that the AuNPs@POM
promote DNA damage in B16 cells, given that this effect is generally
accompanied by cell cycle arrest, although further experiments
should be conducted to prove this. Importantly, arrest in G0/G1 or
G2/M phases have been extensively described with antitumoural
drugs,30 different types of NPs31 and even polyoxometalates.32
Quantification of the cell internalisation of AuNPs@POM
Accordingly we wanted to better understand the susceptibility
of the B16 cell line to AuNPs@POM and, based on the significant
internalisation observed from TEM images, postulated that it
was due to a higher internalisation of the particles when
compared with the Vero line. To quantify the internalised
particles within both Vero and B16 cells comprehensive ICP
analyses were performed. In order to do this only the highest
concentration of 0.1 mg mL1 was selected for incubation with
Vero and B16 and each analysis was performed in duplicate to
verify reproducibility. Therefore, after 24 h of incubation with
0.1 mg mL1 AuNPs@POM, cells were washed thrice with PBS
Fig. 3 Concentration-dependent cell apoptosis/necrosis effects induced
in (a) Vero and (b) B16 cells following incubation with AuNPs@POM at
37 1C for 24 h. Cells were double-stained with annexin V/propidium iodide
(PI) and analysed by flow cytometry.
Fig. 4 Concentration-dependent effect of AuNPs@POM on cell cycle arrest and DNA fragmentation in: (a) Vero and (b) B16 cells. Cells were incubated
with different concentrations of AuNPs@POM for 24 h at 37 1C and cell cycle analysis was assessed using a PI stain and flow cytometry.
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and digested first with piranha solution and then with aqua regia
for 1 and 3 h, respectively. Finally, all samples were incubated at
60 1C for 15 min and diluted withMilli-Q water. To calculate the Au
content per cell, the same number of B16 and Vero cells were
seeded but were left blank (no NPs were added) for the same period
of time as samples treated with AuNPs@POM. This enabled us to
count the number of cells using Trypan blue.
ICP analysis revealed that B16 cells incorporated 42% of all
administrated AuNPs@POM, where each individual cell assimilated
21 pg of Au. Surprisingly, Vero cells internalised 58% of the
administered AuNPs@POM, giving a total of 34 pg of Au per cell.
The higher amount of AuNPs@POM internalised by the Vero
cells was not in agreement with our original hypothesis, where
we expected higher internalisation by the B16 tumoural cells. But
despite the massive internalisation of AuNPs, the Vero cells
remain largely unaffected by the administered dose. Importantly,
these differences in cellular uptake of the AuNPs@POM from one
cell type to another can be ascribed to the diverse uptake efficiency
of the two investigated lines (each cell line displays different
kinetics, endocytosis mechanisms, cellular metabolism, and so
forth).33 On the other hand, MTT assays, apoptosis/necrosis and
cell cycle data have shown that the AuNPs@POM are more toxic to
the B16 cells despite the lower internalisation when compared to
the Vero cells. Remarkably, analysis of the Mo content shows that
B16 and Vero cells internalised 91 fg and 21 fg per cell, respectively.
Therefore one hypothesis is that the observed toxicity to the B16
tumoural cell line is associated with the AuNP mediated delivery of
high concentrations of Mo into the cells. It is important to note,
however, that the accumulation of NPs in both cell types is
exceptionally large and it is remarkable that the Vero cell line
remains largely unaffected by the presence of such large quantities
of internalised NPs, while the same particles exert a pronounced
antiproliferative action on the B16 tumoural cell line.
Conclusions
In summary, we report how polyoxometalate-stabilised gold
nanoparticles (AuNPs@POM) internalise readily and in vast
quantities into Vero (kidney epithelial) and B16 (skin mela-
noma cells) cell lines. All together, our results indicate that
AuNPs@POM caused greater antiproliferative action on B16
tumour cells than on Vero cells.
TEM imaging shows that the AuNPs@POM are located in the
endosomes, far from the nucleus of the cells and that none are
associated to the cytoplasmic membrane. The results of MTT cell
viability assays coupled with apoptosis/necrosis studies by flow
cytometry reveal that Vero cells remain largely unaltered by the
internalisation of these hybrid particles, while the viability of the
B16 cell line was affected at the highest tested concentrations.
The deleterious effects in B16 cells was verified by analysing the
cellular cycle. Control cell viability assays (ESI†) showed that
the molecular POM species at the same concentrations found on
the AuNPs@POM were ineffective against either cell line, thus
illustrating some sort of synergistic antiproliferative effect of the
AuNPs@POM on B16 tumoural cells.
The cytotoxicity profile of these hybrid POM-stabilised NPs
in normal vs. tumoural cell lines coupled with the high degree
of internalisation (determined from ICP analysis) means that
these (or similar) hybrid particles could serve as candidates for
a range of applications in diagnostics or therapy, for example as
potential antitumour therapies. These results provide new
insights into POM chemistry and nanoparticle science and
the antiproliferative action of the particles in B16 cells poses
motivating questions to stimulate new avenues of research.
There are various potential mechanisms through which these
hybrid particles may exert their cytotoxic effect on B16 cells, and
more extensive investigations will be needed to elucidate the exact
cellular-internalisation pathway(s) and inhibitory mechanism(s)
through which these particles operate. In this respect, the use of
fluorescently labelled POMs would greatly facilitate this endeavour,
where additional in vitro information could be gained using dark
field microscopy to pinpoint the AuNPs, coupled with confocal
and/or optical microscopy to locate the labelled POM. Concern-
ing any potential medical applications of these hybrid materials,
the selection of POMs that will exert a desired (antimicrobial,
antitumoural or antiviral) response that are loaded onto nano-
particle supports for efficient delivery to cells will be critical. For
increased specificity, click chemistry could be used34 to conjugate
cell-penetrating peptides to the POM to direct the payload to its
desired location, further increasing the efficacy of the bioactive
POM.35
Experimental
Materials and methods
All chemicals and solvents were of analytical grade purchased
from Sigma Aldrich and used as supplied, without further
purification. Pure water was used throughout by passing water
through a Millipore-Q Academic purification set. UV-vis Spectro-
scopy: all samples were measured in aqueous suspension at
room temperature using a Varian Cary 50 UV-visible spectro-
meter over the range of 200–1100 nm in 1 cm quartz cuvettes.
High-Resolution Transmission Electron Microscopy (HR-TEM):
all samples were deposited on carbon-covered Cu200 mesh
grids and data were collected on a FEI Tecnai TF20 200 kV
FEG high resolution TEM. Inductively coupled plasma atomic
emission spectroscopy (ICP-AES): data were collected under
Argon gas using an IRIS Intrepid Radial Thermoelemental
equipped with an Echelle optical system (381 mm) and a solid
state Charge Injection Device (CID) (28 mm  28 mm). Flow
Cytometry: cell membrane integrity was measured on a BD
Biosciences FACSAriat (Becton Dickinson Company) cell
sorter using a commercial staining kit from IMMUNOSTEP
(ref: ANXVFK-100T); the cell cycle analysis was analysed using
a FACSArrayt (Becton Dickinson Company) cell sorter using
propidium iodide (PI) stain.
Preparation of AuNPs@POM
The AuNPs@POM were prepared and characterised according
to a reported experimental procedure.21
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Cell lines
Vero are kidney epithelial cells from African green monkey
(Cercopithecus aethiops). B16 are skin melanoma cells lines
isolated from mouse (Mus musculus). Both cells lines were
acquired from the American Type Culture Collection (ATCC):
Vero (CCL-81) and B16 (CRL-6475).
Cells were cultured at 37 1C in a 5% CO2 atmosphere in
Dulbecco’s modified Eagle’s medium (DMEM) (Lonza) supple-
mented with 10% foetal bovine serum (FBS), 5% glutamine and
5% penicillin/streptomycin.
Transmission electron microscopy analysis of fixed cells
2  104 of B16 cells were seeded in an 8-well chamberslide
(permanox, Nunc) and allowed to replicate overnight at 37 1C
(5% of CO2 and humidified atmosphere). Thereafter, cells were
incubated with 0.1 mg mL1 of AuNPs@POM for 24 h then
washed with PBS to remove free particles before being fixed
with 2.5% glutaraldehyde in 0.1 M phosphate buffered saline
(PBS) for 1 hour at 4 1C. The cells were then washed four times
with 0.1 M PBS. Sections were post-fixed with 2% osmium
tetroxide, rinsed, dehydrated and embedded in Durcupan resin
(Fluka, Sigma-Aldrich, St. Louis, USA). Semi-thin sections (1.5 mm)
were cut with an Ultracut UC-6 (Leica, Heidelberg, Germany) and
stained lightly with 1% toluidine blue. Finally, ultra-thin sections
(0.08 mm) were cut with the microtome, stained with lead citrate
(Reynolds solution) and examined under a 200 keV FEI Tecnai T20
(FEI Europe, Eindhoven, Netherlands) operating at 80 keV.
MTT cell viability assays
Vero or B16 cells were seeded in 96-multiwell plate at a density
of 1  104 cells per well and incubated overnight at 37 1C (5%
CO2 and humidified atmosphere). After 24 hours the medium
was replaced with a fresh DMEM for the positive controls
(100% cell viability) and with DMEM with the AuNPs@POM
adjusted to the desired concentrations (0.1, 0.07, 0.05 and
0.02 mg mL1). It is important to note that the water content
of the nanoparticle suspensions was always less than 10%, i.e.
to obtain the final concentration of AuNPs@POM the original
suspensions were centrifuged to remove water and diluted to
the desired volume with DMEM so that the final volume
contained no more than 10% water. All cells were incubated
for 24 hours prior to performing theMTT assay. Excess mediumwas
removed and the cells were washed trice with PBS (to remove any
excess non-internalized particles and dead cells) and then 200 mL of
DMEM containing 20 mL of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) 5 mg mL1 was added to the cells.
The 96-multiwell plate was incubated in the dark for three
hours and centrifuged (one hour, 1260 rpm). MTT is converted
by living cells into violet formazan crystals and this metabolic
product was solubilised by replacement of the MTT-containing
medium with 200 mL of dimethyl sulfoxide (DMSO). After
mixing, the optical density at 570 nm was recorded using a
plate reader (ELx800TM, Biotek (Thermo Scientific Multiskan
GO UV/Vis microplate spectrophotometer)). Sextets were performed
(twice) for the control experiments and for each concentration
of AuNPs@POM to determine the standard deviation and reprodu-
cibility of the results. Statistical analysis: one-way Anova for B16 and
for Vero (separately) and Tukey’s multiple comparison test were
performed using the GraphPadPrism software.
Quantification of apoptosis/necrosis by flow cytometry
Cells were seeded in 12-multiwell plates at a density of 2  105
cells per well and allowed to replicate overnight at 37 1C (5% of
CO2 and humidified atmosphere). After 18 hours the DMEM
was replaced by fresh medium for the positive control (100%
viability) and by medium with the AuNPs@POM at different
concentrations (0.1, 0.07, 0.05 and 0.02 mg mL1). The cells
were then incubated for 24 hours. After removal of the solutions
and washing the cells twice with PBS each cell experiment was
harvested with trypsin. Afterwards each of the cell experiments were
resuspended in medium and transferred to an Eppendorf vial,
centrifuged (6 min/1260 rpm). In the case of the cells incubated
with AuNPs@POM a dark precipitate could clearly be observed at
the bottom of the Eppendorf vials corresponding to the cells with
internalised AuNPs@POM. The supernatant from the centrifuga-
tion was discarded and the cells were resuspended in 1 mL of PBS.
Finally, all of the cell samples were centrifuged and resuspended in
buffer to be stained with a commercial kit (Annexin V-FITC
Apoptosis Detection Kit, ref. ANXVFK-100T) from Immunostep,
S.L. and then incubated in the dark at room temperature for
15 minutes. Flow cytometry data were collected on a FACSAriaTM
(Becton Dickinson Company) flow cytometer.
Cell cycle analysis by flow cytometry
Cells for cell cycle analysis were prepared in the same manner
as for apoptosis/necrosis analysis using flow cytometry. How-
ever, following incubating cells with AuNPs@POM for 24 h,
harvesting the cells and centrifuging for 6 min, the supernatant
was discarded and the cells were resuspended in 1 mL of PBS.
This suspension was centrifuged one more time for 6 min at
1260 rpm and resuspended in 200 mL of PBS. Subsequently
1 mL of cold 70% ethanol was added dropwise under vortex
shaking. Cells were stored at 4 1C and overnight and the
following day were centrifuged one final time before being
resuspended in a buffer containing 50 mg mL1 of propidium
iodide (PI) and 100 mg mL1 of RNAse A and incubated at room
temperature for 30 minutes in the dark. The cell cycle was
analysed by flow cytometry using a FACSArrayTM (Becton Dickinson
Company).
ICP analysis
2  105 of B16 and Vero cells were seeded in 12-multiwell plates
and allowed to replicate overnight at 37 1C (5% CO2 and
humidified atmosphere). After 24 h the medium was removed
and another one containing AuNPs@POM at 0.1 mg mL1 was
added (Vf H2O o10%). The cells were left for another 24 h to
allow their internalisation. In the case of the control cell
samples, i.e. cells without AuNPs@POM for cell counting and
for blank subtraction, the medium was replaced with fresh one.
Thereafter, cells with and without AuNPs@POM were thoroughly
washed with PBS, and harvested with trypsin. Afterwards medium
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for trypsin neutralisation was added and the cells were transferred
from each plate to an individual Eppendorf vial. Following the
centrifugation (6 min/1260 rpm) the supernatants were discarded
and cells processed for ICP analysis (see below for further details).
Blank cells (without AuNPs@POM) that had been seeded for
cell counting were resuspended in fresh medium directly after
discarding their supernatants and were counted with the use of
Trypan blue. To digest the samples for ICP analysis, cells pellets
and the 100% sample of the AuNPs@POM from centrifugation
were each treated with 100 mL of Piranha solution (3 : 1 85%
sulfuric acid : 50% hydrogen peroxide) for 1 h followed by 300 mL
aqua regia (1 : 3 nitric : hydrochloric acid) for 3 h. Subsequently
the samples were incubated at 60 1C for 15 min and diluted with
Milli-Q water to 20 mL. Samples were evaluated by ICP-AES and
or ICP-MS (Optima 8300, Perkin Elmer).
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